ICNSl logo no-tagline copy

PEER REVIEWED, EVIDENCE-BASED INFORMATION FOR CLINICIANS AND RESEARCHERS IN NEUROSCIENCE

What’s in a name? That which we call Psychiatry 2010 by any other name would smell as sweet

Dear Colleagues:

Goodbye 2009; hello Psychiatry 2010! As we ring in the ‘Ten,’ we of course update the journal’s name to reflect the new year. But what is the journal’s real name?

Over the last several years (and we are entering our seventh year of publication, loyal readers), many of you have asked that very question. Are we Psychiatry 2010? Psychiatry MMC? Psychiatry (Edgemont) [or is it (Edgmont)]? Or is it just Psychiatry? Informally, these names are all correct. Officially, however, the name of the journal is simply Psychiatry. We add the year to signify that the peer-reviewed, evidence-based information found within these (digital) pages is the most up-to-date information that evidence has supported thus far.

So, where do these other names come from? The journal website url is www.innovationscns.com (MMC stands for Matrix Medical Communications), so it is not unusual to see the journal cited as Psychiatry MMC, though technically this is not correct. As for the elusive Psychiatry (Edgmont), this is the name given to us by PubMed to distinguish the journal from two other journals named Psychiatry—Edgemont refers to the city in which our journal is published, and yes, PubMed mysteriously dropped the middle ’e.’

So call the journal what you may! It will still provide you, practicing clinicians, with the latest peer-reviewed, evidence-based information in the field of psychiatry.

And now we welcome you to the January issue of Psychiatry 2010. We start the issue with Sansone and Sansone’s Interface installment. The authors review the literature regarding the misuse/abuse potential of quetiapine, an atypical antipsychotic. According to the available evidence, there is a current demographic profile for the type of patient who is most at risk to abuse this drug, which the authors describe and discuss.

Next, Rais et al examine, through an open-label study, the safety and efficacy of ziprasidone intramuscular with geriatric patients experiencing psychosis or agitation. The authors found that there were significant improvements in scores on a variety of measures assessing agitation or psychosis.

Following this, Sanders and Gillig review the functional and anatomical relationships between cranial nerves V and VII in both their sensory and motor divisions. The authors briefly review the anatomy of these cranial nerves, disorders of these nerves that are of particular importance to psychiatry, and some considerations for differential diagnosis.

Next, Lee et al provide a case of a 21-year-old man who presented in a state of delirium with compulsive, pathologic laughter and no focal neurologic findings. Brain imaging revealed a lenticulostriate artery infarct of the caudate nucleus. The authors emphasize the importance of brain imaging in this case, which had “…confusing clinical features [that] could be mistaken for a psychiatric disorder and result in delays at diagnosis and intervention.”

Following this, Prabhakar and Balon present a case of a 76-year-old woman who presented secondary mania and was eventually diagnosed with late-onset bipolar disorder. As the authors describe and discuss, “…a thorough work-up to rule out secondary causes remains the centerpiece of correctly diagnosing and effectively treating late-onset bipolar disorder.”

Finally we wrap up the issue with two of our regular columns. In Meymandi at Large, Dr. Meymandi captivates us with an eloquent description of a “kingly” book by Francis Oakley; and the experts at PRMS offer some sound advice on terminating a treatment relationship.

Sincerely,

Amir Kalali, MD
Editor, Psychiatry 2010